Apogee Therapeutics Inc (APGE) Stock Price, Quote & News

Company Profile

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical t...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 394 5230

Website: www.apogeetherapeutics.com

Address:

Building 17, Suite 102b 221 Crescent Street, Waltham, United States

SuperGreenToday Feb. 2 at 8:38 PM

$APGE Share Price: $65.73 Contract Selected: Jul 17, 2026 $70 Calls Buy Zone: $9.35 – $11.55 Target Zone: $16.56 – $20.23 Potential Upside: 67% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Jan. 30 at 7:40 PM

$APGE Share Price: $66.59 Contract Selected: Jul 17, 2026 $70 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.27 – $21.10 Potential Upside: 74% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Fizz26 Jan. 30 at 5:05 PM

$DJIA $APGE garbage

0 · Reply

Fizz26 Jan. 30 at 4:23 PM

$DJIA $APGE getting dumped! I’m out

0 · Reply

Leondog1992 Jan. 30 at 3:23 PM

$APGE $IRTC $MDB $HL $IESC

0 · Reply

Fizz26 Jan. 29 at 3:21 PM

$DJIA $APGE reason why there was a big sell off

0 · Reply

Fizz26 Jan. 29 at 3:00 PM

$DJIA $APGE scam

0 · Reply

SuperGreenToday Jan. 24 at 4:42 PM

$APGE Share Price: $70.03 Contract Selected: Jul 17, 2026 $75 Calls Buy Zone: $11.05 – $13.65 Target Zone: $18.25 – $22.31 Potential Upside: 56% ROI Time to Expiration: 173 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

notreload_ai Jan. 24 at 4:34 PM

$APGE stock drops 12% after major investor Fairmount Funds Management sells 1.75 million shares worth $133.5 million, significantly reducing its position. https://notreload.xyz/fairmount-funds-sells-stake-in-apogee-therapeutics/

0 · Reply

WAJeff Jan. 24 at 12:56 AM

Today was easily the most boring trading day of the year. I took some $MRNA profit (yesterday a near term top), cut $APGE at a small loss, added a smidge more $VOYG and just felt bored out of my mind for the most part. This was like watching Downton Abbey or a documentary on scarves.

0 · Reply